CELLACT PHARMA
CellAct Pharma GmbH was founded by Fritz Kopitzki and Nalân Utku in 2007 as a venture backed biotech company. CellAct is focused on the development of innovative therapeutics for the treatment of various cancers.
CELLACT PHARMA
Industry:
Biotechnology
Address:
Dortmund, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.cellact.eu
Status:
Active
Contact:
+49 23197426350
Email Addresses:
[email protected]
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Google Maps Apache 2.2 Debian Online.net
Official Site Inspections
http://www.cellact.eu Semrush global rank: 5.25 M Semrush visits lastest month: 1.56 K
- Host name: static.212.19.40.188.clients.your-server.de
- IP address: 188.40.19.212
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "CellAct Pharma"
CellAct Pharma - Crunchbase Company Profile & Funding
Organization. CellAct Pharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +49 …See details»
CellAct Pharma - VentureRadar
CellAct Pharma GmbH has been founded by Fritz Kopitzki and Nalân Utku in 2007 as a venture backed biotech company focused on the development of innovative therapeutics for the …See details»
CellAct Pharma GMBH
CellAct Pharma GMBH Targeting unmet needs in inflammation and cancer BioMedizinZentrum Otto-Hahn-Strasse 15 D-44227 Dortmund, Germany Phone: +49 23197426350 Web Site: …See details»
CELLACT Pharma - Overview, News & Competitors | ZoomInfo.com
CELLACT Pharma contact info: Phone number: +49 23197426350 Website: www.cellact.eu What does CELLACT Pharma do? CellAct Pharma is focused on the development of innovative …See details»
Organization | CellAct Pharma GmbH
CellAct Pharma GmbH Report issue. For profit Phase 2. Founded: Dortmund Germany (2007 ... Organization Overview. First Clinical Trial. 2011 NCT02094560. First Marketed Drug. None …See details»
CELLACT Pharma GmbH
CellAct Pharma leverages its network of world leading academic institutions to supplement own resources in the research and development of novel therapeutics as well as with industrial …See details»
CellAct Pharma GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CellAct Pharma GmbH of Dortmund, Nordrhein-Westfalen. Get the latest business insights from Dun …See details»
Company directory - zfp-do.de
Cellact Pharma GmbH CellAct Pharma GmbH is a venture backed biotech company focused on the development of innovative therapeutics for the treatment of diseases with high unmet …See details»
CellAct Pharma - Company Profile - Tracxn
Oct 17, 2024 CellAct Pharma ranks 1,956th among 2364 active competitors. 847 of its competitors are funded while 545 have exited. Overall, CellAct Pharma and its competitors …See details»
CellAct Pharma GmbH - Dortmund, Germany - bionity.com
Oct 19, 2009 CellAct Pharma is focused on the development of innovative therapeutics for the treatment of diseases with high unmet need, especially certain cancers and inflammatory …See details»
CellAct Pharma - PitchBook
CellAct Pharma General Information Description. Developer of innovative therapeutics designed to offer treatment against various forms of cancer. The company's therapeutics target and modulate human molecules that have …See details»
CellAct - Products, Competitors, Financials, Employees, …
Headquarters Location. BioMedizinZentrum Otto-Hahn-Strasse 15. Dortmund, 44227, Germany. 49 23 197 42 63 50See details»
Cellact - Crunchbase Company Profile & Funding
Cellact provides SMS, USSD and Voice products for mobile operators around the world. Cellact’s solution are currently installed in more than 50 mobile operators. Their products allow the …See details»
CellAct Pharma | VentureRadar
Similar Companies: NOXXON Pharma Germany Publicly Traded NOXXON Pharma AG (Berlin, Germany) based on one of the biggest and best protected patent portfolios in the industry, …See details»
CellAct Pharma GmbH Asset Profile | Preqin
Established in 2007 and based in Dortmund, Germany, CellAct Pharma GmbH is a biotechnology company that focuses on the development of therapeutics for the treatment of various types of …See details»
CELLACT Pharma GmbH
Heinemann T, Bulwin GC, Randall J, et al. Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation. Genomics, 57(3) 398-406, 1999. Utku …See details»
Wissenschafts- und Technologiecampus Dortmund
Cellact Pharma GmbH CellAct Pharma GmbH is a venture backed biotech company focused on the development of innovative therapeutics for the treatment of diseases with high unmet …See details»
Mundipharma buys rights to CellAct cancer drug - pharmaphorum
Aug 14, 2017 European independent pharma network Mundipharma has bought worldwide rights to develop, market and manufacture cancer drug CAP7.1 from Germany’s CellAct. A …See details»
Press Release - cellact.eu
CellAct Pharma Advances Phase I Clinical Trial of Topoisomerase Inhibitor in Cancer Contacts: Nalân Utku, M.D. Managing Director CellAct Pharma Tel: +49 231 9742 6350 …See details»
Mundipharma and CellAct announce new deal for the worldwide …
Companies announced today that it has acquired from CellAct the worldwide development, commercialization and manufacturing rights to CAP7.1. CAP7.1 is a novel pro-drug of …See details»